van der Meer FJM - Search Results

1

Inter- and intra-individual concentrations of direct oral anticoagulants: The KIDOAC study.

Toorop MMA, van Rein N, Nierman MC, Vermaas HW, Huisman MV, van der Meer FJM, Cannegieter SC, Lijfering WM. Toorop MMA, et al. Among authors: van der meer fjm, van rein n. J Thromb Haemost. 2022 Jan;20(1):92-103. doi: 10.1111/jth.15563. Epub 2021 Nov 4. J Thromb Haemost. 2022. PMID: 34664401 Free PMC article.

2

Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound.

van Rooden CJ, Rosendaal FR, Barge RM, van Oostayen JA, van der Meer FJ, Meinders AE, Huisman MV. van Rooden CJ, et al. Br J Haematol. 2003 Nov;123(3):507-12. doi: 10.1046/j.1365-2141.2003.04638.x. Br J Haematol. 2003. PMID: 14617015 Free article.

3

Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.

Huisman MV, van der Meer FJ, van Rooden CJ, Prins MH. Huisman MV, et al. N Engl J Med. 2003 Nov 27;349(22):2164-7; author reply 2164-7. doi: 10.1056/NEJM200311273492216. N Engl J Med. 2003. PMID: 14645647 No abstract available.

4

The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.

Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV. Van Rooden CJ, et al. Haematologica. 2004 Feb;89(2):201-6. Haematologica. 2004. PMID: 15003896

5

Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study.

van Rooden CJ, Schippers EF, Barge RM, Rosendaal FR, Guiot HF, van der Meer FJ, Meinders AE, Huisman MV. van Rooden CJ, et al. J Clin Oncol. 2005 Apr 20;23(12):2655-60. doi: 10.1200/JCO.2005.05.002. J Clin Oncol. 2005. PMID: 15837979 Free article. Clinical Trial.

6

Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.

van Rooden CJ, Schippers EF, Guiot HF, Barge RM, Hovens MM, van der Meer FJ, Rosendaal FR, Huisman MV. van Rooden CJ, et al. J Clin Oncol. 2008 Jan 20;26(3):428-33. doi: 10.1200/JCO.2007.11.7754. J Clin Oncol. 2008. PMID: 18202420 Clinical Trial.

7

The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.

van Leeuwen Y, Rosendaal FR, van der Meer FJ. van Leeuwen Y, et al. Thromb Res. 2008;123(2):225-30. doi: 10.1016/j.thromres.2008.01.020. Epub 2008 Apr 14. Thromb Res. 2008. PMID: 18407321 Clinical Trial.

8

Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma.

van den Besselaar AM, Witteveen E, van der Meer FJ. van den Besselaar AM, et al. Thromb Haemost. 2008 Dec;100(6):1181-4. doi: 10.1160/th08-04-0257. Thromb Haemost. 2008. PMID: 19132246

9

Subtherapeutic oral anticoagulant therapy: frequency and risk factors.

Rombouts EK, Rosendaal FR, van der Meer FJ. Rombouts EK, et al. Thromb Haemost. 2009 Mar;101(3):552-6. Thromb Haemost. 2009. PMID: 19277419

10

Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.

Torn M, Cannegieter SC, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR. Torn M, et al. Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176. Arch Intern Med. 2009. PMID: 19597069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters